Latest Stock Market News

Mysore-based Kaynes Technology is a leading end-to-end and IoT (Internet of Things) solutions-enabled integrated electronics manufacturing player, having capabilities across the entire spectrum of electronics system design and manufacturing services.

Health officials in China reiterated their commitment to strict COVID-19 curbs over the weekend, disappointing investors hopeful for a relief. Separately, data showed Chinese exports and imports both contracted in October and missed forecasts.

Jhunjhuwala added stakes in two new counters during the period while she likely exited three companies, suggests latest shareholding pattern. Further, Jhunjhunwala increased her stakes in as many as five existing holdings and cut stakes in three others. She kept her stake unchanged in seven counters.

On November 2, the stock clocked around 20% gains after strong earnings for the quarter ended September. During the quarter, the Mangaluru-headquartered bank posted an all-time high quarterly net profit of Rs 411.5 crore, recording 228% growth compared to the profit during the same period last year.

The Nifty Auto index closed 1.3 per cent up at 13443.9.

"During the quarter, we continued to demonstrate strong GMV growth with improvement in gross margin, efficiency in fulfilment and marketing cost lead to improvement in EBITDA margin YoY," Nykaa said in an exchange filing.

The Relative Strength Index (RSI) is at 68.1. RSI below 30 is considered oversold and above 70 is considered overbought, Trendlyne data showed. MACD is above its center and signal Line, which is a bullish indicator.

"Britannia’s growth acceleration is likely more backed by the success of its own GTM (go-to-market) strategy and increase in distribution reach, we reckon. Subsidiaries’ (Dairy + International) performance was more subdued - sales growth of just 4.8% while EBITDA declined by 11.2%," JM Financial said.

“It is not as if we do not invest in small and midcaps. We have capped that investment at a certain level, particularly in smallcaps because in smallcaps, the risk is when things go out suddenly, the liquidity disappears. We do not want to take those kinds of chances. That is why we will never be 40% smallcaps or something like that.”

​​The Hyderabad-based drugmaker disappointed the Street which was estimating a profit of Rs 630 crore.